01486nas a2200529   4500000000100000000000100001008004100002260001500043653002300058653001900081653001200100653001600112653001800128653002600146653002000172653003500192100001900227700001800246700001800264700001900282700002300301700002500324700001600349700002100365700002700386700002000413700001400433700001900447700002600466700002100492700001600513700002100529700001800550700002000568700002000588700002500608700001700633700001800650700001800668700001900686700002100705700002000726245011300746856007700859490000600936022001400942       2026                            d  c2026-06-1510aCP: cancer biology10aCP: immunology10aT cells10aco-cultures10aImmunotherapy10atumor microenviroment10atumor organoids10atumor-infiltrating lymphocytes1 aEnrique Podaza1 aJared Capuano1 aHui-Hsuan Kuo1 aMajd Al Assaad1 aGeoffrey Markowitz1 aM. Victoria Revuelta1 aJohn Nguyen1 aAdriana Irizarry1 aHiranmayi Ravichandran1 aSarah Ackermann1 aTroy Kane1 aJyothi Manohar1 aAlyssa Duren-Lubanski1 aMichael Sigouros1 aJenna Moyer1 aBhavneet Bhinder1 aPooja Chandra1 aMurtaza Malbari1 aKarsten Boehnke1 aJuan Miguel Mosquera1 aVivek Mittal1 aAndrea Sboner1 aHamza Gokozan1 aNasser Altorki1 aOlivier Elemento1 aM. Laura Martin00aTumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC  uhttps://www.cell.com/cell-reports-methods/abstract/S2667-2375(26)00039-10 v6  a2667-2375